These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38496341)
1. Scoping Review: The Role of Psychedelics in the Management of Chronic Pain. Robinson CL; Fonseca ACG; Diejomaoh EM; D'Souza RS; Schatman ME; Orhurhu V; Emerick T J Pain Res; 2024; 17():965-973. PubMed ID: 38496341 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Are psychedelics the answer to chronic pain: A review of current literature. Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI Pain Pract; 2023 Apr; 23(4):447-458. PubMed ID: 36597700 [TBL] [Abstract][Full Text] [Related]
4. Psychedelics for treatment resistant depression: are they game changers? Kalfas M; Taylor RH; Tsapekos D; Young AH Expert Opin Pharmacother; 2023; 24(18):2117-2132. PubMed ID: 37947195 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of psychedelics in psychiatry, a systematic review of the literature]. Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297 [TBL] [Abstract][Full Text] [Related]
6. Psychedelics in the Treatment of Headache and Chronic Pain Disorders. Schindler EAD Curr Top Behav Neurosci; 2022; 56():261-285. PubMed ID: 35546382 [TBL] [Abstract][Full Text] [Related]
7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder. Velit-Salazar MR; Shiroma PR; Cherian E Brain Sci; 2024 Mar; 14(3):. PubMed ID: 38539636 [TBL] [Abstract][Full Text] [Related]
9. Psychedelics as a potential treatment for tobacco use disorder: a systematic review. Spoelstra SK; Schoevers RA; Venema SD; Knegtering H Discov Ment Health; 2024 Sep; 4(1):37. PubMed ID: 39289250 [TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies. Low ZXB; Ng WS; Lim ESY; Goh BH; Kumari Y Prog Neuropsychopharmacol Biol Psychiatry; 2024 Sep; ():111139. PubMed ID: 39251080 [TBL] [Abstract][Full Text] [Related]
11. The use of classic psychedelics among adults: a Danish online survey study. Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202 [TBL] [Abstract][Full Text] [Related]
12. Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Hinkle JT; Graziosi M; Nayak SM; Yaden DB JAMA Psychiatry; 2024 Sep; ():. PubMed ID: 39230883 [TBL] [Abstract][Full Text] [Related]
14. Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review. Zhornitsky S; Oliva HNP; Jayne LA; Allsop ASA; Kaye AP; Potenza MN; Angarita GA Front Psychiatry; 2023; 14():1197890. PubMed ID: 37435405 [TBL] [Abstract][Full Text] [Related]
15. Use of Psychedelics for Pain: A Scoping Review. Goel A; Rai Y; Sivadas S; Diep C; Clarke H; Shanthanna H; Ladha KS Anesthesiology; 2023 Oct; 139(4):523-536. PubMed ID: 37698433 [TBL] [Abstract][Full Text] [Related]
16. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080 [TBL] [Abstract][Full Text] [Related]
17. Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans. Madrid-Gambin F; Fabregat-Safont D; Gomez-Gomez A; Olesti E; Mason NL; Ramaekers JG; Pozo OJ Biomed Pharmacother; 2023 Dec; 169():115775. PubMed ID: 37944438 [TBL] [Abstract][Full Text] [Related]
18. Adapting psychedelic medicine for headache and chronic pain disorders. Schindler EAD; Hendricks PS Expert Rev Neurother; 2023; 23(10):867-882. PubMed ID: 37652000 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of psilocybin in addiction: A systematic review. van der Meer PB; Fuentes JJ; Kaptein AA; Schoones JW; de Waal MM; Goudriaan AE; Kramers K; Schellekens A; Somers M; Bossong MG; Batalla A Front Psychiatry; 2023; 14():1134454. PubMed ID: 36846225 [TBL] [Abstract][Full Text] [Related]
20. Dosing Psychedelics and MDMA. Liechti ME; Holze F Curr Top Behav Neurosci; 2022; 56():3-21. PubMed ID: 34734392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]